KLOW
A four-compound regenerative research blend — the GLOW formulation with KPV added for inflammatory-signaling work.
Research Overview
KLOW is the GLOW blend with the addition of KPV, the C-terminal tripeptide of α-MSH. Where GLOW’s three constituents are studied in repair and matrix signaling, KPV research centres on NF-κB inhibition and pro-inflammatory cytokine expression.
The stated rationale for the four-compound form is to place repair-pathway and inflammatory-pathway compounds in one preparation for combined in-vitro work. KPV’s reported activity appears largely independent of melanocortin receptors, pointing to an intracellular mechanism.
Specifications
| Compound | KLOW |
| Classification | Regenerative research compound |
| Constituents | BPC-157 10 mg — 1,419.5 g/mol GHK-Cu 50 mg — 404.92 g/mol TB-500 10 mg — 4,963.4 g/mol KPV 10 mg — 410.51 g/mol |
| Molecular weight | Blend — see constituents |
| Sequence / Form | BPC-157 10 mg · GHK-Cu 50 mg · TB-500 10 mg · KPV 10 mg |
| Purity | ≥98% HPLC, identity verified by mass spectrometry |
| Documentation | Batch-specific Certificate of Analysis available |
| Appearance | White lyophilized powder |
| Storage | Store sealed at 2–8°C. Long-term storage per certificate guidance. |
| Use | Research Use Only. Not for human or veterinary use. |
Quality Documentation
Every released lot is supported by quality-control documentation. Certificate access is presented by compound and lot where available. Cold-chain shipping is available where required; inventory is held under refrigerated conditions at our fulfillment center with temperature-logging protocols in place.
Research Use Only
This product is offered strictly for laboratory research use. It is not a drug, food, cosmetic, supplement, or consumer product, and is not intended for human or veterinary use.
